Investing legends, Rentokil and AstraZeneca: The Companies and Markets Show

Investors' Chronicle

We begin with Mark Robinson who covers pest control business Rentokil (RTO) which saw a double digit surge in its share price after rumours of private-equity takeovers began swirling.

It’s then on to this week’s cover story by James Norrington on the investing greats and how investors can apply their wisdom to their own portfolios.

Jennifer Johnson then joins the conversation with an update on leader of the FTSE 100, AstraZeneca (AZN). Why are shares down despite its guidance being upgraded? And what does the company offer outside of oncology drugs?

Last up, we cover energy company Centrica’s (CNA) results which received a less than favourable market reaction.

1:27 Rentokil (RTO)

12:53 Investing greats

23:50 AstraZeneca (AZN)

33:31 Centrica (CNA)

Claim your first 12 weeks of Investors' Chronicle Print + Digital for just £12. You will get instant access to our website and app, plus the magazine delivered to your door every week. To start your trial, visit www.investorschronicle.co.uk/podcasttrial

*After your 12-week trial you will pay just £62 every 13 weeks by direct debit. If you’re not entirely satisfied, you can cancel up to 5 business days before your renewal date and only pay the £12 already debited. This offer is for UK subscribers only.

---

Hosted on Acast. See acast.com/privacy for more information.